Form 4: Capricor Therapeutics Director Exercises Stock Options
SEC Form 4 Filing
Director Earl M. Collier Jr. exercised stock options to acquire 750 shares of Capricor Therapeutics common stock at $1.39 per share.
Summary
- On February 27, 2025, Earl M. Collier Jr., a director of Capricor Therapeutics, exercised stock options.
- This transaction involved the acquisition of 750 shares of common stock at a price of $1.39 per share.
- Following the transaction, Collier directly owns 57,606 shares of Capricor Therapeutics.
- The stock options were granted on March 3, 2015, and were adjusted due to a reverse stock split and share reprice.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment, but rather reports a factual transaction.
Positives
- The director's exercise of options could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into insider transactions. This filing indicates a director's exercise of stock options, which is a common occurrence.
Key Dates
| Date | Description |
|---|---|
| 2015-03-03 | Date the stock options were granted. |
| 2019-06-04 | Date of the 1-for-10 reverse stock split. |
| 2020-02-12 | Date of the share reprice to $1.39 per share. |
| 2025-02-27 | Date of the transaction (exercise of stock options). |
| 2025-02-28 | Date of signature on the Form 4 filing. |
| 2025-03-03 | Date the shares were fully vested and exercisable. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.